GNPX · Genprex, Inc.

Genprex Inc Is A Clinical-Stage Gene Therapy Company Focused On Developing Life-Changing Therapies For Patients With Cancer And Diabetes. Its Technologies Are Designed To Administer Disease-Fighting Genes To Provide New Therapies For Large Patient Populations With Cancer And Diabetes Who Currently Have Limited Treatment Options. Genprex'S Oncology Program Utilizes Its Systemic, Non-Viral Oncoprex Delivery System, Which Encapsulates The Gene-Expressing Plasmids Using Lipid-Based Nanoparticles In A Lipoplex Form. The Company'S Product Candidate, Reqorsa Gene Therapy (Quaratusugene Ozeplasmid), Is Initially Being Developed In Combination With Prominent, Approved Cancer Drugs To Treat Non-Small Cell Lung Cancer (Nsclc) And Small Cell Lung Cancer (Sclc).